Bioventix PLC Stock OTC Markets
Stocks
BVNXF
GB00B4QVDF07
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 03-30 | BioVentix confident on future despite profit decline in first half | AN |
| 03-30 | WINNERS & LOSERS: boohoo to beat view; Abingdon Health wins deals | AN |
| Market Cap | 86.21M 114M 100M 95.06M 162M 10.92B 163M 1.14B 440M 5.58B 427M 418M 17.95B | P/E 2026 * |
12.3x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 81.32M 107M 94.77M 89.66M 152M 10.3B 154M 1.08B 415M 5.26B 403M 394M 16.93B | EV / Sales 2026 * |
6.51x | EV / Sales 2027 * | - |
| Free-Float |
92.29% | Yield 2026 * |
9.09% | Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Harrison
CEO | Chief Executive Officer | 67 | 23/12/2003 |
| Director of Finance/CFO | 67 | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Harrison
BRD | Director/Board Member | 67 | 25/11/2010 |
Ian Nicholson
CHM | Chairman | 66 | 01/11/2004 |
| Director/Board Member | 67 | 01/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 114M | |
| -0.70% | -4.28% | +52.62% | +86.42% | 71.53B | |
| -0.45% | +1.17% | +37.01% | +81.07% | 60.12B | |
| -1.11% | +3.13% | +9.90% | +37.79% | 48.85B | |
| +0.12% | -0.41% | +48.84% | +36.72% | 44.28B | |
| +0.00% | +6.03% | +343.85% | +638.73% | 43.83B | |
| +2.76% | -0.76% | +9.75% | +103.07% | 41.53B | |
| +0.34% | +0.22% | +5.18% | +47.36% | 30.13B | |
| +4.77% | +6.16% | +36.77% | +26.10% | 27.98B | |
| +0.09% | -4.30% | -18.37% | +357.94% | 25.25B | |
| Average | +0.60% | -0.06% | +58.39% | +157.24% | 43.72B | |
| Weighted average by Cap. | +0.37% | -0.16% | +63.10% | +147.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.5M 16.51M 14.57M 13.78M 23.44M 1.58B 23.67M 165M 63.73M 809M 61.98M 60.64M 2.6B | - |
| Net income | 7.11M 9.39M 8.29M 7.84M 13.33M 901M 13.47M 94.08M 36.26M 460M 35.27M 34.5M 1.48B | - |
| Net Debt | -4.89M -6.46M -5.7M -5.4M -9.18M -620M -9.27M -64.74M -24.95M -317M -24.27M -23.74M -1.02B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BVXP Stock
- BVNXF Stock
Select your edition
All financial news and data tailored to specific country editions
